Snake venom VEGF Vammin induces a highly efficient angiogenic response in skeletal muscle via VEGFR-2/NRP specific signaling

Autor: Minna U. Kaikkonen, Seppo Ylä-Herttuala, Tommi Heikura, Johanna P. Laakkonen, Pyry I. Toivanen, Tiina Nieminen
Přispěvatelé: A.I. Virtanen -instituutti, A.I. Virtanen -instituutti / Bioteknologia ja molekulaarinen lääketiede
Jazyk: angličtina
Rok vydání: 2017
Předmět:
0301 basic medicine
Vascular Endothelial Growth Factor A
medicine.medical_specialty
Angiogenesis
Molecular biology
Science
Neovascularization
Physiologic

Nerve Tissue Proteins
Viper Venoms
Biology
Biochemistry
Article
Neovascularization
03 medical and health sciences
0302 clinical medicine
Internal medicine
medicine
Human Umbilical Vein Endothelial Cells
Animals
Humans
Therapeutic angiogenesis
Amino Acid Sequence
Muscle
Skeletal

Calcium signaling
Cell Proliferation
Regulation of gene expression
Sprouting angiogenesis
Multidisciplinary
Molecular medicine
Snakes
Vascular Endothelial Growth Factor Receptor-2
Recombinant Proteins
Cell biology
Protein Structure
Tertiary

030104 developmental biology
Endocrinology
Nuclear receptor
Medicine
Rabbits
Signal transduction
medicine.symptom
Mitogen-Activated Protein Kinases
Structural biology
Sequence Alignment
030217 neurology & neurosurgery
Signal Transduction
Zdroj: Scientific Reports
Scientific Reports, Vol 7, Iss 1, Pp 1-12 (2017)
Popis: Vascular Endothelial Growth Factors (VEGFs) are promising molecules for the treatment of ischemic diseases by pro-angiogenic therapy. Snake venom VEGFs are a novel subgroup with unique receptor binding profiles and as such are potential new therapeutic agents. We determined the ligand-receptor interactions, gene regulation and angiogenic properties of Vipera ammodytes venom VEGF, Vammin, and compared it to the canonical angiogenic factor VEGF-A to evaluate the use of Vammin for therapeutic angiogenesis. Vammin efficiently induced VEGFR-2 mediated proliferation and expression of genes associated with proliferation, migration and angiogenesis. VEGF-A165 and especially VEGF-A109 induced less pronounced effects. Vammin regulates a number of signaling pathways by inducing the expression of NR4A family nuclear receptors and regulators of calcium signaling and MAP kinase pathways. Interestingly, MARC1, which encodes an enzyme discovered to catalyze reduction of nitrate to NO, was identified as a novel VEGFR-2 regulated gene. In rabbit skeletal muscle adenoviral delivery of Vammin induced prominent angiogenic responses. Both the vector dose and the co-receptor binding of the ligand were critical parameters controlling the type of angiogenic response from sprouting angiogenesis to vessel enlargement. Vammin induced VEGFR-2/NRP-1 mediated signaling more effectively than VEGF-A, consequently it is a promising candidate for development of pro-angiogenic therapies.
published version
peerReviewed
Databáze: OpenAIRE